// App-Quantinova.ai

108 : Transferrin Is Downregulated in Alcoholic Hepatitis and Predicts Short‐term Survival

Researchers

Presenter

  • Karim Hamesch

Principal Investigators

  • Stephen R. Atkinson

  • Igor Spivak

  • Nurdan Gueldiken

  • Joaquin Cabezas

  • Josepmaria Argemi

  • Ramon Bataller

  • Christian Trautwein

  • Mark R. Thursz

  • Pavel Strnad

Medical Centers

  • Medical Clinic III, Gastroenterology, Metabolic diseases and Intensive Care, University Hospital RWTH Aachen, Aachen, Germany, Aachen, Germany

  • Department of Histopathology, Imperial College London, London, United Kingdom

  • UNC Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, NC

  • Gastroenterology and Hepatology, Hospital Marques de Valdecilla, Santander, Spain

  • Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA

Locations

  • Germany

  • United Kingdom

  • United States

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Alcoholic hepatitis

Biomarkers

  • Ferritin

  • Transferrin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved